Selected scientific papers
This section contains a selection of Dr. Breggin's scientific articles spanning 1964 to the present. They can be arranged chronologically in order to facilitate an overview of his work over the years.
"Should the Use of Neuroleptics Be Severely Limited?" In S.A Kirk and Susan D. Einbinder P (ed): Controversial Issues in Mental Health. Boston: Allyan and Bacon, 1994, pp 146-152. Reprinted in Changes: An International Journal of Psychology and Psychotherapy 14:62-66 March 1996.
The return of lobotomy and psychosurgery 01/01/1982
"The Return of Lobotomy and Psychosurgery." Reprinted with a new introduction in Edwards RB (ed): Psychiatry and Ethics. Buffalo, Prometheus Books, 1982. Originally published in the Congressional Record , February 24, 1972, E1602-E1612. First reprinted in Quality of Health Care-Human Experimentation: Hearings Before Senator Edward Kennedy's Subcommittee on Health, US Senate, Washington, D.C., US Government Printing Office, 1973.
Psychiatry's role in the holocaust (1993) 01/01/1993
"Psychiatry's Role in the Holocaust." International Journal of Risk and Safety in Medicine 4:133-148, 1993. Adapted from a paper delivered at "Medical Science Without Compassion" in Cologne, Germany and published in the conference proceedings.
Brain damage, dementia and persistent cognitive dysfunction associated with neuroleptics (1990) 01/01/1990
"Brain damage, dementia and persistent cognitive dysfunction associated with neuroleptics: Evidence, Etiology, Implications." Journal of Mind Behavior 11:425-464, 1990.
"Suicidality, Violence and Mania Caused by Selective Serotonin Reuptake Inhibitors (SSRIs): A Review and Analysis." International Journal of Risk and Safety in Medicine, 16: 31-49, 2003/2004. Originally published in Ethical Human Sciences and Services, 5:225-246.
Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medication. International Journal of Risk & Safety in Medicine, 23: 193-200.
Peter R. Breggin, MD
Abstract: Understanding the hazards associated with long-term exposure to psychiatric drugs is very important but rarely emphasized in the scientific literature and clinical practice. Drawing on the scientific literature and clinical experience, the author describes the syndrome of Chronic Brain Impairment (CBM) which can be caused by any trauma to the brain including Traumatic Brain Injury (TBI), electroconvulsive therapy (ECT), and long-term exposure to psychiatric medications. Knowledge of the syndrome should enable clinicians to more easily identify long-term adverse effects caused by psychiatric drugs while enabling researchers to approach the problem with a more comprehensive understanding of the common elements of brain injury as they are manifested after long-term exposure to psychiatric medications. Treatment options are also discussed.
Disabling the brain with electroshock (1981) 02/01/1981
"Disabling the Brain with Electroshock." Divergent Views in Psychiatry, M. Dongier and E. Wittkower, editors. Harper and Row, Hagerstown, MD, 247-271, 1981.
Politics, practice, and breaking news (2006) 02/01/2006
"Politics, Practice, and Breaking News." Ethical Human Psychology and Psychiatry, 8, 3-6, 2006.
"Drug Company Suppressed Data on Paroxetine-Induced Stimulation: Implications for Violence and Suicide", Ethical Human Psychology and Psychiatry, 8, 255-263, 2006.
"How GlaxoSmithKline Suppressed Data on Paxil-Induced Akathisia: Implications for Suicidality and Violence", Ethical Human Psychology and Psychiatry, 8, 91-100, 2006.